Telemedicine can dramatically improve coverage of HIV prevention medication

A new study led by researchers at Emory University’s Rollins School of Public Health, published Monday by JAMA Network Open, estimates that nearly 20% of U.S. residents who use pre-exposure prophylaxis (PrEP) for HIV prevention—or more than…

Continue Reading

News Source: medicalxpress.com